Autologous adipose derived stem cell therapy for intervertebral disc degeneration |
Bundang CHA Hospital, Korea |
NCT02338271 |
Recruiting |
Treatment of degenerative disc disease with allogeneic mesenchymal stem cells |
Hospital Clinico Universitario, Valladolid, Spain |
NCT01860417 |
Ongoing, not recruiting |
Autologous adipose tissue derived mesenchymal stem cell transplantation in patient with lumbar intervertebral disc degeneration |
Biostar, Korea University Anam Hospital |
NCT01643681 |
Unknown |
Safety and preliminary efficacy study of mesenchymal precursor cells (MPCs) in subjects with lumbar back pain |
Mesoblast Ltd. |
NCT01290367 |
Completed but no results posted |
Safety and efficacy study of rexlemestrocel-L (viz. allogenic MSCs) in subjects with chronic discogenic lumbar back pain |
Mesoblast Ltd. |
NCT02412735 |
Recruiting |
Lumbar degenerative disc disease treatment with bone marrow autologous mesenchymal stem cells (MSV) |
Red de Terapia Celular, Spain |
NCT02440074 |
Withdrawn |
Human autograft mesenchymal stem cell mediated stabilization of the degnerative lumbar spine |
Trinity Stem Cell Institution, Odessa, Florida, USA |
NCT02529566 |
Enrolling by invitation |
Adipose cells for degenerative disc disease |
Bioheart Inc. |
NCT02097862 |
Recruiting |
Safety and efficacy with NOVOCART disc plus (ADCT) for the treatment of degenerative disc disease in lumbar spine (NDisc) |
Tetec AG |
NCT01640457 |
Ongoing, not recruiting |
A study comparing the safety and effectiveness of cartilage cells injected into the lumbar disc as compared to a placebo |
ISTO Technologies Inc., USA |
NCT01771471 |
Ongoing, not recruiting |